Dear Biostatisticians:
The Biostatistics and Pharmaceutical Statistics (BioPharm) Section of
the International Society for Bayesian Analysis (ISBA) is cordially
inviting you to a free one hour Zoom event on career development.
We have assembled a distinguished international panel of experts to give
us their thoughts on academia, industry and government careers.
Deborah Ashby
Director of the School of Public Health at Imperial College London
London, England, United Kingdom
Scott Berry
President and Senior Statistical Scientist at Berry Consultants, LLC
Austin, Texas, United States
Nicky Best
Leader of the Advanced Biostatistics and Data Analytics Centre of Excellence at GSK
London, England, United Kingdom
Gregory Campbell
Principal Biostatistician at GCStat Consulting
Silver Spring, Maryland, United States
Frank Harrell
Professor of Biostatistics at Vanderbilt University
Nashville, Tennessee, United States
This one hour Zoom event will take place on 03/25/2021
starting at 10:30 CDT, 11:30 EDT, 3:30 GMT, 4:30 CET.
Please register on the Google form at the following URL
https://forms.gle/Zb2P3fv2PGpAkegZA
N.B. on the form, you will have an opportunity to suggest
a question for our panel.
Sincerely,
Rodney Sparapani
Chair, on behalf of the officers of the BioPharm Section of ISBA.
You can find more information about our section at the following URL.
https://isba-biostatspharma.github.io
Please consider joining. For students and those in developing
countries, send an email to our Secretary Lisa Hampson at
mailto:lisa.hampson@novartis.com to be added to our mailing list.
Panelist Biographies
Deborah Ahsby
Director of the School of Public Health
Imperial College London, UK
https://www.linkedin.com/in/deborah-ashby-6a724210/
Professor Ashby holds the Chair in Medical Statistics and Clinical Trials,
and was Founding Co-Director of Imperial Clinical Trials Unit. She is a
Chartered Statistician. Her research interests are in clinical trials, risk-
benefit decision making for medicines, and Bayesian approaches in these
areas. Deborah is the immediate Past President of the Royal Statistical
Society. She has sat on the UK Commission on Human Medicines and
acted as adviser to the European Medicines Agency. Dr. Ashby has
recently chaired the Population Research Committee for Cancer
Research UK and the National Institute for Health Research HTA
Commissioning Board, and was Deputy Chair of the HTA Programme.
Deborah was awarded the OBE for services to medicine in 2009,
appointed an NIHR Senior Investigator in 2010, and elected to the
Academy of Medical Sciences in 2012.
Scott Berry
President and Senior Statistical Scientist at Berry Consultants, LLC
Austin, Texas, United States
https://www.linkedin.com/in/scott-berry-52b8025b/
At Berry Consultants, Scott works on the design of innovative clinical trials,
Bayesian statistics, and clinical trial simulation. He earned his PhD in statistics
from Carnegie Mellon University and was an Assistant Professor at Texas A&M
University before co-founding Berry Consultants in 2000. Dr. Berry was elected
as a Fellow of the American Statistical Association in 2013.
Nicky Best
Leader of the Advanced Biostatistics and Data Analytics Centre of Excellence at GSK
London, England, United Kingdom
https://www.linkedin.com/in/nicky-best-36188bb7/
At GlaxoSmithKline (GSK), Professor Best leads a team of UK- and
US-based statisticians innovating methodology for clinical trial design,
analysis and decision-making strategies. In 2015, Nicky was awarded
the RSS/PSI award for Statistical Excellence in the Pharmaceutical
Industry for her role in implementing prior elicitation and statistical
assurance to improve decision making in clinical development. In 2018,
she received the RSS Bradford Hill Medal for her work on Bayesian
methods in clinical trials, cost-effectiveness, epidemiology and drug
development. She currently co-chairs the EFSPI/PSI Historical Data
Special Interest Group. Before joining the pharmaceutical industry,
Nicky was an academic statistician at the Medical Research Council
Biostatistics Unit in Cambridge UK and Imperial College London, where
she was professor of Statistics and Epidemiology. Her academic research
focused on development and application of Bayesian methods in health
and social science, and she is co-developer of the BUGS Bayesian
software package.
Gregory Campbell
Principal Biostatistician at GCStat Consulting
Silver Spring, Maryland, United States
https://www.linkedin.com/in/gregory-campbell-55588548/
Dr. Campbell got his PhD from Florida State University in Mathematical Statistics.
He held positions at Purdue University and the US National Institutes
of Health before becoming the Director of Biostatistics at the US Food and
Drug Administration. Currently, he is a Principal Biostatistician at GCStat
Consulting. He has numerous publications and book chapters on
Bayesian statistics and Bayesian analysis of pharmaceuticals and devices.
Frank Harrell
Professor of Biostatistics at Vanderbilt University
Nashville, Tennessee, United States
https://www.fharrell.com
Dr. Harrell received his PhD from the University of North Carolina
in Biostatistics. He held positions at Duke University and the
University of Virginia before arriving at Vanderbilt. He has
numerous publications, books and book chapters on biostatistics
from both the frequentist and Bayesian perspectives.
------------------------------
Rodney Sparapani, Associate Professor of Biostatistics
Chair ISBA Section on Biostatistics and Pharmaceutical Statistics
Institute for Health and Equity, Division of Biostatistics
Medical College of Wisconsin, Milwaukee Campus
------------------------------